Tata Group is planning on Research and Development by FY26 and is set to roll out the 'First in India' seating system for Vande Bharat Express trains from September 2022.
Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
EXAMIANS